Role of epidermal growth factor (EGF) in oesophageal mucosal integrity.
Oesophageal mucosa has well established protective mechanisms, which operate within pre-epithelial, epithelial and post-epithelial compartments. Since refluxed acid and pepsin always act from the luminal side of the mucosa, protective factors like EGF, operating as a part of pre-epithelial defence, are thought to be pivotal in the maintenance of the integrity of the oesophageal mucosa. The significant contribution of salivary EGF to the quality of the oesophageal mucosal barrier has been demonstrated in an experimental setting and in a clinical scenario. Patients with low salivary EGF levels are predisposed to severe oesophageal damage if they develop gastro-oesophageal reflux and are a high-risk group for development of Barrett's oesophagus. Not only the salivary glands but also the human oesophagus has a profound ability to elaborate and release EGF. Some changes in luminal release of EGF during oesophageal mucosal exposure to intraluminal damaging factors imply its role in the oesophageal protective mechanisms. To exert biological effects within the oesophageal mucosal compartment, EGF requires binding to the ligand-binding domain of its receptor. This process results in receptor dimerisation, autophosphorylation and activation of intracellular signal transduction pathways. EGF receptors are localised on the basolateral and luminal aspect of the mucosal cells playing an important role in fast regeneration of oesophageal epithelium through the high mitotic activity of its proliferative zone. An increase in the rate of salivary EGF secretion during masticatory stimulation suggests its potential therapeutic benefit in the treatment of patients with damaged oesophageal mucosa.
Marcinkiewicz
M
M
Department of Gastroenterology, J. Sniadecki's District Hospital, Bialystok, Poland.
Grabowska
S Z
SZ
Czyzewska
E
E
D001471:Barrett Esophagus / Q000209:etiology*; D004815:Epidermal Growth Factor / Q000032:analysis* / Q000502:physiology*; D004947:Esophagus / Q000502:physiology*; D005764:Gastroesophageal Reflux / Q000150:complications*; D006801:Humans; D009092:Mucous Membrane / Q000502:physiology; D012463:Saliva / Q000737:chemistry* / Q000378:metabolism*
D004815:Epidermal Growth Factor